glp-1 obesity drug news today oct 2025 New weight-loss drugs surge in popularity amid surge in US, worldwide GLP-1 Receptor Agonists Obesity Drugs

Gill says if NAION is confirmed, consult with your full medical team, including your ophthalmologist, neurologist, primary care physician and endocrinologist, to make a well-informed decision on whether to continue or stop the GLP-1 medication

The Bottom Line ReflexMd is a solid choice if you are looking for affordable tirzepatide options

However, patients should be aware that allulose is still counted in total carbohydrates on nutrition labels, which may be relevant for carbohydrate counting

At the same time, obesity is showing up more often across the world, and there is also more public awareness about obesity related health complications which, is pushing people toward better solutions

Additional research published in ASM Journals has explored the crosstalk between glucagon-like peptide 1 and gut microbiota in metabolic diseases, documenting the complex interactions between gut bacteria composition, bacterial metabolites, and GLP-1 signaling pathways

Antagonism of rat beta-cell voltage-dependent k+ currents by exendin 4 requires dual activation of the cAMP/protein kinase a and phosphatidylinositol 3-kinase signaling pathways